A Pharmacokinetic Evaluation Study in Healthy Volunteers

NCT00210054 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2015-10-12

No results posted yet for this study

Summary

The purpose of this trial is to characterize the pharmacokinetics of INS37217 following intravenous administration.

Conditions

  • Healthy

Interventions

DRUG

denufosol tetrasodium (INS37217)

Sponsors & Collaborators

Principal Investigators

  • Robin Deterding, MD

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-11-30
Primary Completion
2002-12-31
Completion
2002-12-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00210054 on ClinicalTrials.gov